Old Articles: <Older 9071-9080 Newer> |
|
Chemistry World April 9, 2015 Emma Stoye |
BMS invests in gene therapy Bristol-Myers Squibb has agreed to invest over $100 million in Netherlands-based biotechnology company uniQure, which specializes in gene therapies for cardiovascular diseases. |
Chemistry World April 2, 2015 Emma Stoye |
Horizon to acquire orphan drugs in $1.1bn Hyperion takeover Horizon will gain two rare disease drugs: Ravicti (glycerol phenylbutyrate) and Buphenyl (sodium phenylbutyrate), which are used to treat urea cycle disorder. |
Chemistry World April 2, 2015 Emma Stoye |
Novartis accused of 'derailing' trials for cheap eye disease drug The British Medical Journal has accused pharmaceutical giant Novartis of deliberately hindering research into the use of anticancer drug Avastin (bevacizumab) to treat age-related wet macular degeneration. |
Information Today April 2, 2015 |
Society of Interventional Radiology Chooses Thieme as Publishing Partner The plan is to publish several books each year about topics in the interventional radiology field. |
Chemistry World April 1, 2015 Sanjay Kumar |
Sun Pharma snares Ranbaxy in $4bn deal Sun Pharma is now the fifth largest generics drug company in the world. |
Chemistry World April 1, 2015 Emma Stoye |
Teva buys Auspex Pharmaceuticals for $3.2bn In a bid to strengthen its position in central nervous system R&D, one of its core therapeutic areas, generics giant Teva is set to acquire US-based biotech firm Auspex Pharmaceuticals. |
HBS Working Knowledge April 1, 2015 Carmen Nobel |
The Slow, Steady Battle to Fix Cancer Care Thomas Feeley is on a quest to make payment procedures for cancer patients easier, hopefully less expensive, and in the process help change how health care is delivered in America. |
CRM April 2015 Leonard Klie |
VoltDelta Is the Right Prescription for Rx Outreach The multichannel cloud contact center solution provides IVR, agent infrastructure, and automated prescription reminders for a mail-order pharmacy. |
CRM April 2015 Oren Smilansky |
Athenahealth Increases Engagement with Force Management's QStream Platform The learning-based gamification program teaches reps better sales techniques. |
Chemistry World March 25, 2015 Phillip Broadwith |
Valeant heads off Endo bid for Salix Valeant has flexed its acquisitive muscles to head off a rival bid for gastroenterology specialist Salix Pharmaceuticals. |
<Older 9071-9080 Newer> Return to current articles. |